Noninvasive Diagnosis of NAFLD and NASH

The aim of this review is to outline emerging biomarkers that can serve as early diagnostic tools to identify patients with nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) and, among them, the subgroup of best candidates for clinical trials on emerging compounds. Reg...

Descripción completa

Detalles Bibliográficos
Autores principales: Piazzolla, Valeria Annarita, Mangia, Alessandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226476/
https://www.ncbi.nlm.nih.gov/pubmed/32316690
http://dx.doi.org/10.3390/cells9041005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226476/
https://www.ncbi.nlm.nih.gov/pubmed/32316690
http://dx.doi.org/10.3390/cells9041005

Ejemplares similares